Simpler PrEP services – fewer check-ups, online care – work as well as the standard approach
Beyond cholesterol: statins may protect heart health in people with HIV through multiple mechanisms
Coronary artery disease uncommon in people with HIV in Uganda
Why aren’t more people with HIV accessing doxyPEP?
HIV acquisition in women with good adherence to TAF/FTC PrEP is rare
New long-acting HIV drugs show promising early results
Broadly neutralising antibody N6LS could be part of long-acting HIV treatment
Injectable PrEP use leads to zero new HIV infections among gay, trans and non-binary Brazilians
Once-yearly PrEP moves closer: experimental lenacapavir formulations show promise
